Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.40
+0.14 (2.32%)
Aug 10, 2026, 12:38 PM EDT - Market open

Bausch Health Companies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10,85310,2669,6258,7578,1248,434
Revenue Growth
10.09%6.66%9.91%7.79%-3.68%5.07%
Gross Profit
7,7957,2536,8436,1985,7606,040
Operating Income
2,7362,1921,8741,6211,4841,708
Net Income
-1,098157-46-592-225-948
Earnings Per Share
-2.950.42-0.13-1.62-0.62-2.64
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Salix
2,8062,5782,3332,2502,0902,074
International Rx
1,1821,1321,1111,0719881,166
Solta Medical
624518440347300308
Diversified Products
9179379509439781,121
Bausch + Lomb
5,3245,1014,7914,1463,7683,765
Revenue (Total)
12,20310,2669,6258,7578,1248,434

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,8251,3091,181947564582
Total Debt
20,77921,07921,83922,59721,00022,918
Net Cash (Debt)
-18,954-19,770-20,658-21,650-20,436-22,336
Net Cash Growth
------
Net Cash Per Share
-50.86-52.72-56.14-59.33-56.45-62.23

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,8001,4001,5971,032-7281,426
Capital Expenditures
-369-397-337-215-218-269
Free Cash Flow
1,4311,0031,260817-9461,157
Free Cash Flow Growth
28.34%-20.40%54.22%--43.02%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
71.82%70.65%71.10%70.78%70.90%71.61%
Operating Margin
25.21%21.35%19.47%18.51%18.27%20.25%
Pretax Margin
-6.74%3.57%1.74%-4.45%-1.59%-12.14%
Profit Margin
-10.12%1.53%-0.48%-6.76%-2.77%-11.24%
FCF Margin
13.18%9.77%13.09%9.33%-11.64%13.72%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-16.40----
Forward PE
1.501.671.902.111.705.92
P/FCF Ratio
1.682.572.353.59-8.57
PS Ratio
0.220.250.310.330.281.18